Hcw Biologics Stock Market Value
| HCWB Stock | USD 0.83 0.16 16.16% |
| Symbol | HCW |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HCW Biologics. Market participants price HCW higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive HCW Biologics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (16.41) | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
Investors evaluate HCW Biologics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating HCW Biologics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause HCW Biologics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between HCW Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if HCW Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, HCW Biologics' market price signifies the transaction level at which participants voluntarily complete trades.
HCW Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HCW Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HCW Biologics.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in HCW Biologics on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding HCW Biologics or generate 0.0% return on investment in HCW Biologics over 90 days. HCW Biologics is related to or competes with In8bio, Neurosense Therapeutics, Adial Pharmaceuticals, Acurx Pharmaceuticals, Transcode Therapeutics, Creative Medical, and Biocardia. HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunothe... More
HCW Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HCW Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HCW Biologics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 41.72 | |||
| Value At Risk | (14.16) | |||
| Potential Upside | 13.02 |
HCW Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for HCW Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HCW Biologics' standard deviation. In reality, there are many statistical measures that can use HCW Biologics historical prices to predict the future HCW Biologics' volatility.| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (1.84) | |||
| Total Risk Alpha | (2.32) | |||
| Treynor Ratio | (0.71) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of HCW Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
HCW Biologics February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.17) | |||
| Market Risk Adjusted Performance | (0.70) | |||
| Mean Deviation | 5.15 | |||
| Coefficient Of Variation | (449.56) | |||
| Standard Deviation | 7.47 | |||
| Variance | 55.85 | |||
| Information Ratio | (0.23) | |||
| Jensen Alpha | (1.84) | |||
| Total Risk Alpha | (2.32) | |||
| Treynor Ratio | (0.71) | |||
| Maximum Drawdown | 41.72 | |||
| Value At Risk | (14.16) | |||
| Potential Upside | 13.02 | |||
| Skewness | 0.5369 | |||
| Kurtosis | 2.13 |
HCW Biologics Backtested Returns
HCW Biologics holds Efficiency (Sharpe) Ratio of -0.26, which attests that the company had a -0.26 % return per unit of volatility over the last 3 months. HCW Biologics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out HCW Biologics' market risk adjusted performance of (0.70), and Coefficient Of Variation of (449.56) to validate the risk estimate we provide. The firm retains a Market Volatility (i.e., Beta) of 2.35, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, HCW Biologics will likely underperform. At this point, HCW Biologics has a negative expected return of -1.83%. Please make sure to check out HCW Biologics' maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if HCW Biologics performance from the past will be repeated at future time.
Auto-correlation | 0.30 |
Below average predictability
HCW Biologics has below average predictability. Overlapping area represents the amount of predictability between HCW Biologics time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HCW Biologics price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current HCW Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.3 | |
| Spearman Rank Test | 0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether HCW Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HCW Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hcw Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hcw Biologics Stock:Check out HCW Biologics Correlation, HCW Biologics Volatility and HCW Biologics Performance module to complement your research on HCW Biologics. For information on how to trade HCW Stock refer to our How to Trade HCW Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
HCW Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.